NovoCure Ltd. (NVCR)
14.99
-0.21
(-1.38%)
USD |
NASDAQ |
Oct 06, 16:00
14.99
0.00 (0.00%)
After-Hours: 20:00
NovoCure EPS Diluted (Quarterly) : -0.135 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.135 |
| March 31, 2026 | -0.6232 |
| December 31, 2025 | -0.2183 |
| September 30, 2025 | -0.333 |
| June 30, 2025 | -0.3598 |
| March 31, 2025 | -0.3112 |
| December 31, 2024 | -0.6077 |
| September 30, 2024 | -0.2824 |
| June 30, 2024 | -0.3099 |
| March 31, 2024 | -0.3613 |
| December 31, 2023 | -0.4401 |
| September 30, 2023 | -0.4635 |
| June 30, 2023 | -0.5402 |
| March 31, 2023 | -0.5022 |
| December 31, 2022 | -0.3552 |
| September 30, 2022 | -0.2534 |
| June 30, 2022 | -0.2295 |
| March 31, 2022 | -0.0446 |
| December 31, 2021 | -0.2547 |
| September 30, 2021 | -0.1265 |
| June 30, 2021 | -0.1415 |
| March 31, 2021 | -0.0402 |
| December 31, 2020 | 0.0445 |
| September 30, 2020 | 0.0854 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0154 |
| March 31, 2020 | 0.0366 |
| December 31, 2019 | 0.0395 |
| September 30, 2019 | 0.0179 |
| June 30, 2019 | -0.0132 |
| March 31, 2019 | -0.1281 |
| December 31, 2018 | -0.1679 |
| September 30, 2018 | -0.13 |
| June 30, 2018 | -0.17 |
| March 31, 2018 | -0.23 |
| December 31, 2017 | -0.12 |
| September 30, 2017 | -0.13 |
| June 30, 2017 | -0.24 |
| March 31, 2017 | -0.21 |
| December 31, 2016 | -0.26 |
| September 30, 2016 | -0.39 |
| June 30, 2016 | -0.48 |
| March 31, 2016 | -0.42 |
| December 31, 2015 | -0.393 |
| September 30, 2015 | -2.09 |
| June 30, 2015 | -2.309 |
| March 31, 2015 | -0.2815 |
| June 30, 2014 | -1.678 |
| March 31, 2014 | -0.2192 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Smith & Nephew plc | -- |
| LivaNova Plc | 1.929 |
| Tristel Plc | -- |
| EKF Diagnostics Holdings Plc | -- |
| Niox Group Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.66M |
| Revenue (Quarterly) | 183.58M |
| Total Expenses (Quarterly) | 199.24M |
| Enterprise Value | 1.553B |
| Gross Profit Margin (Quarterly) | 77.61% |
| Profit Margin (Quarterly) | -8.53% |
| Earnings Yield | -8.74% |
| Normalized Earnings Yield | -8.736 |